Table 4 Duration of treatment until symptom improvement (efficacy population)
Parameter | Duration until improvement | ||
|---|---|---|---|
n | Mean | SD | |
Anthonisen grade | |||
Type I | 1084 | 3.6 | (1.5) |
Type II | 1011 | 3.3 | (1.4) |
Type III | 409 | 3.4 | (1.4) |
Missing | 16 | 4.2 | (1.6) |
Concomitant diseases of special interest | |||
COPD | 1667 | 3.5 | 1.4 |
Asthma | 412 | 3.4 | 1.4 |
Emphysema | 602 | 3.6 | 1.5 |
Bronchiectasis | 162 | 3.8 | 1.4 |
Cor pulmonale | 268 | 3.6 | 1.4 |
Cardiomyopathy | 157 | 3.5 | 1.5 |
Cardiac ischemia | 582 | 3.7 | 1.6 |
Heart insufficiency | 138 | 3.1 | 1.3 |
Cardiac arrhythmia | 151 | 3.7 | 1.6 |
Diabetes | 255 | 3.6 | 1.7 |